Belantamab mafodotin

• Target:

  Antibody-Drug Conjugates (ADCs)

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Purity:

  0.9914

• Bioactivity:

  Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2050232-20-5